FDA Approves Lipfendra: Potential Treatment Transformation and Side Effects
The FDA’s recent authorization of Lipfendra, a novel cholesterol-lowering agent, offers a potent alternative for patients who cannot tolerate statins or fail to reach LDL targets. While this medication transforms ... Read More